[Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
Modern views on the pathological mechanism, clinical symptoms and therapeutic management of neonatal myasthenia gravis are reviewed on the basis of literature reports and own experiences. Particular attention is given to intensive medical care in this condition.
Krauze
M
M
II Katedry i Kliniki Pediatrii Sl. Ak. Med, Katowicach.
Musialik
E
E
Swietliński
J
J
Litwa
K
K
Latko
E
E
Górny
J
J
Sobczyk
J
J
D000109:Acetylcholine / Q000276:immunology*; D001323:Autoantibodies / Q000032:analysis / Q000276:immunology*; D001327:Autoimmune Diseases / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005078:Exchange Transfusion, Whole Blood; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal; D009157:Myasthenia Gravis / Q000151:congenital / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D009469:Neuromuscular Junction / Q000187:drug effects / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000276:immunology*
D001323:Autoantibodies; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D000109:Acetylcholine
Myasthenia gravis u noworodków--patomechanizm, symptomatologia kliniczna, postepowanie lecznicze.